Connor, Clark & Lunn Investment Management Ltd.

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in BDTX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$2,254,385

+$663,467 QoQ

Shares Held

1,058,397

+61.7% QoQ

Ownership

1.85%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $706,217,766 across 100 Biotechnology names. BDTX ranks #55 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	251,711	$112,399,029
2	IONS	Ionis Pharmaceuticals Inc	874,089	$65,635,343
3	ARWR	Arrowhead Pharmaceuticals, Inc.	836,981	$52,478,708
4	MIRM	Mirum Pharmaceuticals, Inc.	479,476	$44,293,992
5	REGN	Regeneron Pharmaceuticals, Inc.	32,164	$24,851,192
6	AXSM	Axsome Therapeutics, Inc.	134,792	$22,782,543
7	SRPT	Sarepta Therapeutics, Inc.	1,019,951	$22,194,133
8	TERN	Terns Pharmaceuticals, Inc.	384,681	$20,280,382

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,254,385	1,058,397	+61.7%	Shares	Sole	2026-05-11
2025-12-31	$1,590,918	654,699	+397.4%	Shares	Sole	2026-02-10
2025-09-30	$498,896	131,635	-46.6%	Shares	Sole	2025-11-13
2024-12-31	$527,897	246,681	-13.2%	Shares	Sole	2025-02-10
2024-09-30	$1,236,065	284,153	-0.9%	Shares	Sole	2024-11-08
2024-06-30	$1,336,702	286,846	-8.8%	Shares	Sole	2024-08-09
2024-03-31	$1,594,525	314,502	+279.5%	Shares	Sole	2024-05-09
2022-09-30	$140,068	82,881	+572.2%	Shares	Sole	2022-11-10
2022-06-30	$30,331	12,330	—	Shares	Sole	2022-08-05
No filing history on record for this holder in this stock.